ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,200 shares, an increase of 136.4% from the December 31st total of 2,200 shares. Based on an average daily volume of 10,900 shares, the days-to-cover ratio is currently 0.5 days.
ProShares Ultra Nasdaq Biotechnology Stock Performance
BIB traded up $1.19 on Thursday, hitting $56.01. 6,411 shares of the company were exchanged, compared to its average volume of 8,543. ProShares Ultra Nasdaq Biotechnology has a 12 month low of $47.19 and a 12 month high of $69.56. The stock’s fifty day moving average is $54.20 and its 200-day moving average is $60.49.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The business also recently announced a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd were issued a dividend of $0.3964 per share. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend was Monday, December 23rd.
Hedge Funds Weigh In On ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Further Reading
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- High Dividend REITs: Are They an Ideal Way to Diversify?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Use the MarketBeat Stock Screener
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 5 Top Rated Dividend Stocks to Consider
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.